
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Gut Microbiota of Critically Ill Patients With COVID-19
Paolo Gaibani, Federica D’Amico, Michele Bartoletti, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 86
Paolo Gaibani, Federica D’Amico, Michele Bartoletti, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 86
Showing 1-25 of 86 citing articles:
Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications
Fen Zhang, Raphaela Iris Lau, Qin Liu, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 5, pp. 323-337
Open Access | Times Cited: 192
Fen Zhang, Raphaela Iris Lau, Qin Liu, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 5, pp. 323-337
Open Access | Times Cited: 192
Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID
Giuseppe Ancona, Laura Alagna, Claudia Alteri, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 67
Giuseppe Ancona, Laura Alagna, Claudia Alteri, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 67
Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review
Yeganeh Farsi, Azin Tahvildari, Mahta Arbabi, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 62
Yeganeh Farsi, Azin Tahvildari, Mahta Arbabi, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 62
Traditional Chinese medicine against COVID-19: Role of the gut microbiota
Zhihua Yang, Yangxi Liu, Lin Wang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112787-112787
Open Access | Times Cited: 45
Zhihua Yang, Yangxi Liu, Lin Wang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112787-112787
Open Access | Times Cited: 45
Dissecting the role of the human microbiome in COVID-19 via metagenome-assembled genomes
Shanlin Ke, Scott T. Weiss, Yang‐Yu Liu
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 42
Shanlin Ke, Scott T. Weiss, Yang‐Yu Liu
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 42
Enterococcus Virulence and Resistant Traits Associated with Its Permanence in the Hospital Environment
Catarina Geraldes, Luís Tavares, Solange Gil, et al.
Antibiotics (2022) Vol. 11, Iss. 7, pp. 857-857
Open Access | Times Cited: 40
Catarina Geraldes, Luís Tavares, Solange Gil, et al.
Antibiotics (2022) Vol. 11, Iss. 7, pp. 857-857
Open Access | Times Cited: 40
Gut microbiota composition during hospitalization is associated with 60-day mortality after severe COVID-19
Marius Trøseid, Jan Cato Holter, Kristian Holm, et al.
Critical Care (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 33
Marius Trøseid, Jan Cato Holter, Kristian Holm, et al.
Critical Care (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 33
The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment
Man Wang, Yuan Zhang, Chunmei Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 30
Man Wang, Yuan Zhang, Chunmei Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 30
Gut microbiota short-chain fatty acids and their impact on the host thyroid function and diseases
María José Mendoza-León, Ashutosh K. Mangalam, Alejandro Regaldiz, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 27
María José Mendoza-León, Ashutosh K. Mangalam, Alejandro Regaldiz, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 27
The Gut–Organ Axis within the Human Body: Gut Dysbiosis and the Role of Prebiotics
Georgia Saxami, Evangelia N. Kerezoudi, Christos Eliopoulos, et al.
Life (2023) Vol. 13, Iss. 10, pp. 2023-2023
Open Access | Times Cited: 27
Georgia Saxami, Evangelia N. Kerezoudi, Christos Eliopoulos, et al.
Life (2023) Vol. 13, Iss. 10, pp. 2023-2023
Open Access | Times Cited: 27
Intestinal barrier dysfunction as a key driver of severe COVID-19
Efthymios P. Tsounis, Christos Triantos, Christos Konstantakis, et al.
World Journal of Virology (2023) Vol. 12, Iss. 2, pp. 68-90
Open Access | Times Cited: 26
Efthymios P. Tsounis, Christos Triantos, Christos Konstantakis, et al.
World Journal of Virology (2023) Vol. 12, Iss. 2, pp. 68-90
Open Access | Times Cited: 26
Gut Microbiome Disruption Following SARS-CoV-2: A Review
Elda Righi, Ilaria Dalla Vecchia, Nina Auerbach, et al.
Microorganisms (2024) Vol. 12, Iss. 1, pp. 131-131
Open Access | Times Cited: 9
Elda Righi, Ilaria Dalla Vecchia, Nina Auerbach, et al.
Microorganisms (2024) Vol. 12, Iss. 1, pp. 131-131
Open Access | Times Cited: 9
Microbial Signatures in COVID-19: Distinguishing Mild and Severe Disease via Gut Microbiota
Julia S. Galeeva, Dmitry E. Fedorov, Elizaveta V. Starikova, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 996-996
Open Access | Times Cited: 9
Julia S. Galeeva, Dmitry E. Fedorov, Elizaveta V. Starikova, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 996-996
Open Access | Times Cited: 9
Meta-analysis of 16S rRNA microbial data identified alterations of the gut microbiota in COVID-19 patients during the acute and recovery phases
Xiaomin Cheng, Yali Zhang, Yifan Li, et al.
BMC Microbiology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 35
Xiaomin Cheng, Yali Zhang, Yifan Li, et al.
BMC Microbiology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 35
SARS CoV-2-Induced Viral Sepsis: The Role of Gut Barrier Dysfunction
Stelios F. Assimakopoulos, Gerasimos Eleftheriotis, Maria Lagadinou, et al.
Microorganisms (2022) Vol. 10, Iss. 5, pp. 1050-1050
Open Access | Times Cited: 30
Stelios F. Assimakopoulos, Gerasimos Eleftheriotis, Maria Lagadinou, et al.
Microorganisms (2022) Vol. 10, Iss. 5, pp. 1050-1050
Open Access | Times Cited: 30
Association between Gut Microbiota and SARS-CoV-2 Infection and Vaccine Immunogenicity
Ho Yu Ng, Wai K. Leung, Ka Shing Cheung
Microorganisms (2023) Vol. 11, Iss. 2, pp. 452-452
Open Access | Times Cited: 22
Ho Yu Ng, Wai K. Leung, Ka Shing Cheung
Microorganisms (2023) Vol. 11, Iss. 2, pp. 452-452
Open Access | Times Cited: 22
Alterations in gut immunological barrier in SARS-CoV-2 infection and their prognostic potential
Gerasimos Eleftheriotis, Efthymios P. Tsounis, Ιωάννα Αγγελετοπούλου, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Gerasimos Eleftheriotis, Efthymios P. Tsounis, Ιωάννα Αγγελετοπούλου, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Gut Microbiome Composition and Dynamics in Hospitalized COVID-19 Patients and Patients with Post-Acute COVID-19 Syndrome
Monta Brīvība, Laila Silamiķele, Līga Birzniece, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 567-567
Open Access | Times Cited: 8
Monta Brīvība, Laila Silamiķele, Līga Birzniece, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 567-567
Open Access | Times Cited: 8
The pediatric gut bacteriome and virome in response to SARS-CoV-2 infection
Antonia Piazzesi, Stefania Pane, Federica Del Chierico, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 8
Antonia Piazzesi, Stefania Pane, Federica Del Chierico, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 8
Corticosteroid Dosing Level, Incidence and Profile of Bacterial Blood Stream Infections in Hospitalized COVID-19 Patients
Ivan Papić, Petra Bistrović, Tomislav Čikara, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 86-86
Open Access | Times Cited: 7
Ivan Papić, Petra Bistrović, Tomislav Čikara, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 86-86
Open Access | Times Cited: 7
Dysbiosis of gut microbiota in patients with severe COVID ‐19
Kentaro Shimizu, Haruhiko Hirata, Natsuko Tokuhira, et al.
Acute Medicine & Surgery (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 5
Kentaro Shimizu, Haruhiko Hirata, Natsuko Tokuhira, et al.
Acute Medicine & Surgery (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 5
Association of Gut Microbiota with Inflammatory Bowel Disease and COVID-19 Severity: A Possible Outcome of the Altered Immune Response
Anju Kaushal, Rashed Noor
Current Microbiology (2022) Vol. 79, Iss. 6
Open Access | Times Cited: 21
Anju Kaushal, Rashed Noor
Current Microbiology (2022) Vol. 79, Iss. 6
Open Access | Times Cited: 21
Predictive model for bacterial co-infection in patients hospitalized for COVID-19: a multicenter observational cohort study
Maddalena Giannella, Matteo Rinaldi, Giulia Tesini, et al.
Infection (2022) Vol. 50, Iss. 5, pp. 1243-1253
Open Access | Times Cited: 20
Maddalena Giannella, Matteo Rinaldi, Giulia Tesini, et al.
Infection (2022) Vol. 50, Iss. 5, pp. 1243-1253
Open Access | Times Cited: 20
Association of gut microbiota with COVID‐19 susceptibility and severity: A two‐sample Mendelian randomization study
Weifeng Shang, Sheng Zhang, Hang Qian, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Closed Access | Times Cited: 11
Weifeng Shang, Sheng Zhang, Hang Qian, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Closed Access | Times Cited: 11
Association between gut microbiota dysbiosis and poor functional outcomes in acute ischemic stroke patients with COVID-19 infection
Jiaying Chen, Xuxuan Gao, Jingru Liang, et al.
mSystems (2024) Vol. 9, Iss. 6
Open Access | Times Cited: 4
Jiaying Chen, Xuxuan Gao, Jingru Liang, et al.
mSystems (2024) Vol. 9, Iss. 6
Open Access | Times Cited: 4